Table 2.
Calculated ratios and mean absolute prediction error (MAPE) for the prediction of plasma concentrations of risperidone and 9-hydroxyrisperidone
| Patient | Risperidone | 9-hydroxyrisperidone | ||
|---|---|---|---|---|
| predicted/observed ratio | MAPE | predicted/observed ratio | MAPE | |
| 4 | 0.64 | 35.9 | 1.01 | 0.7 |
| 5 | 0.66 | 33.7 | 1.34 | 34.4 |
| 6 | 0.84 | 16.1 | 1.06 | 5.9 |
| 7 | 0.70 | 29.8 | 0.67 | 32.7 |
| 8 | 1.06 | 5.7 | 0.88 | 12.4 |
| 9 | 1.86 | 86.1 | 3.42 | 241.8 |
| 10 | 1.57 | 56.7 | 1.00 | 0.3 |
| 11 | 0.82 | 18.3 | 0.61 | 38.6 |
| 12 | 0.80 | 19.9 | 0.75 | 25.2 |
| 13 | 0.40 | 60.3 | 0.96 | 3.9 |
| 14 | 0.65 | 35.2 | 1.23 | 22.9 |
| 15 | 2.60 | 159.9 | 1.84 | 84.4 |
| 16 | 1.10 | 10.3 | 0.99 | 1.3 |
| 17 | 1.22 | 21.9 | 0.76 | 23.7 |
| 18 | 0.90 | 9.6 | 1.07 | 7.1 |
| 19 | 0.56 | 43.8 | 0.99 | 0.6 |
| 20 | 0.40 | 59.7 | 1.00 | 0.0 |